CRIS Current Research Information System

SARACINO, ILARIA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.150
AS - Asia 3.741
EU - Europa 2.886
SA - Sud America 225
Continente sconosciuto - Info sul continente non disponibili 199
AF - Africa 142
OC - Oceania 1
Totale 11.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.056
IT - Italia 1.239
SG - Singapore 1.040
CN - Cina 988
VN - Vietnam 837
GB - Regno Unito 359
HK - Hong Kong 279
SE - Svezia 252
DE - Germania 245
BR - Brasile 179
FR - Francia 152
IN - India 141
NL - Olanda 136
KR - Corea 127
RU - Federazione Russa 110
IE - Irlanda 97
BD - Bangladesh 82
CA - Canada 59
FI - Finlandia 56
JP - Giappone 53
UA - Ucraina 51
JO - Giordania 50
ZA - Sudafrica 49
BG - Bulgaria 34
CI - Costa d'Avorio 26
ID - Indonesia 26
AT - Austria 24
EE - Estonia 21
SC - Seychelles 20
CH - Svizzera 19
PH - Filippine 19
ES - Italia 18
TH - Thailandia 16
AR - Argentina 15
IQ - Iraq 13
BE - Belgio 11
EC - Ecuador 11
MX - Messico 11
TN - Tunisia 11
TR - Turchia 11
TW - Taiwan 11
GR - Grecia 10
MA - Marocco 10
PK - Pakistan 9
TG - Togo 9
LT - Lituania 8
PL - Polonia 7
SA - Arabia Saudita 7
PT - Portogallo 6
RO - Romania 6
AL - Albania 5
CO - Colombia 5
HR - Croazia 5
JM - Giamaica 5
CL - Cile 4
EG - Egitto 4
IR - Iran 4
MY - Malesia 4
PE - Perù 4
PY - Paraguay 4
RS - Serbia 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
LB - Libano 3
PS - Palestinian Territory 3
SV - El Salvador 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
GH - Ghana 2
IL - Israele 2
KZ - Kazakistan 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CU - Cuba 1
GD - Grenada 1
GN - Guinea 1
GP - Guadalupe 1
HN - Honduras 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
QA - Qatar 1
Totale 11.141
Salva come PNG Salva come JPEG
Città #
Singapore 729
Ashburn 385
Hefei 316
Southend 298
Hong Kong 268
Chandler 244
San Jose 224
Ho Chi Minh City 195
Fairfield 193
Santa Clara 184
Hanoi 156
Bologna 150
Seoul 119
Dong Ket 108
Woodbridge 108
Beijing 105
Council Bluffs 104
Milan 104
Dublin 97
Princeton 96
Boardman 90
Houston 84
Seattle 82
New York 81
Wilmington 81
Los Angeles 79
Rome 71
Lauterbourg 65
Ann Arbor 62
Cambridge 61
Amman 50
Tokyo 50
Buffalo 41
Helsinki 37
Turin 37
Atlanta 33
Sofia 33
Berlin 31
Redmond 31
Westminster 31
Nanjing 30
Tappahannock 30
Padova 29
Bengaluru 28
Parma 27
Abidjan 26
Dallas 24
Naples 24
Redondo Beach 24
Da Nang 23
Guangzhou 23
Haiphong 23
Jinan 23
Nuremberg 23
Jacksonville 22
São Paulo 22
Munich 21
Shanghai 20
Frankfurt am Main 19
Lappeenranta 17
Biên Hòa 16
Florence 16
Jakarta 16
Bari 15
Montreal 15
Rimini 15
Yubileyny 15
Amsterdam 14
Chicago 14
Johannesburg 14
San Diego 14
Shenyang 14
Toronto 14
Modena 13
Phoenix 13
Verona 13
Zhengzhou 13
Changsha 12
San Francisco 12
Vienna 12
Des Moines 11
Frattamaggiore 11
Orem 11
Shenzhen 11
Bern 10
Brooklyn 10
Brussels 10
Denver 10
Hebei 10
Catania 9
Hải Dương 9
Lomé 9
London 9
Nanchang 9
Norwalk 9
Quận Bình Thạnh 9
Saint Petersburg 9
Columbus 8
Curitiba 8
Hangzhou 8
Totale 6.261
Salva come PNG Salva come JPEG
Nome #
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 612
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 610
Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results 474
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 393
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 272
Palmitoylethanolamide (PEA) for Prevention of Gastroesophageal Inflammation: Insights from In Vitro Models 235
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 226
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 223
Clove Essential Oil as a Source of Antitumoral Compounds Capable of Crossing the Blood–Brain Barrier: A Focus on the Effects of β-Caryophyllene and Eugenol in a Glioblastoma Cell Line 222
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 202
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 197
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 197
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 190
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 187
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 185
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 180
Therapy for H. pylori: Current concepts 172
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 170
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 170
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 167
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 165
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 165
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 164
The Bidirectional Link between Nutritional Factors and Inflammatory Bowel Diseases: Dietary Deficits, Habits, and Recommended Interventions-A Narrative Review 162
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 160
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 159
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 159
Probiotici ricombinanti e loro potenziale sulla salute umana 153
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 150
Diagnosi dell'infezione da Helicobacter pylori 150
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 147
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 147
Recombinant probiotics and their potential in human health 145
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 141
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 140
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 140
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 138
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 137
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 134
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 132
Gluten-Free Diet and Other Celiac Disease Therapies: Current Understanding and Emerging Strategies 132
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 129
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 127
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 127
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 126
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 124
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 123
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 122
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 118
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 116
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 115
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 112
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 109
Very-Low-Absorbable Geraniol for the Treatment of Irritable Bowel Syndrome: A "Real-World" Open-Label Study on 1585 Patients. 109
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 106
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 105
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 103
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 103
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 98
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 95
Rescue Therapies for H. pylori Infection in Italy 91
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 84
null 81
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 78
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 75
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 75
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 71
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 69
null 62
A new non-invasive tool for guiding H. pylori treatment. 54
Antibiotic resistance and therapy for H. Pylori infection in immigrant patients treated in Italy 33
Totale 11.344
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022783 0 27 42 84 85 27 28 68 34 35 237 116
2022/20231.073 87 121 69 119 63 82 44 79 234 52 67 56
2023/2024628 29 102 43 76 35 99 32 40 19 52 60 41
2024/20251.980 97 243 155 137 280 124 152 91 64 105 150 382
2025/20264.323 359 449 367 363 387 268 458 157 760 360 239 156
2026/2027917 622 295 0 0 0 0 0 0 0 0 0 0
Totale 11.344